| The immune landscape of cancer V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ... Immunity 48 (4), 812-830. e14, 2018 | 4999 | 2018 |
| A global view of hepatocellular carcinoma: trends, risk, prevention and management JD Yang, P Hainaut, GJ Gores, A Amadou, A Plymoth, LR Roberts Nature reviews Gastroenterology & hepatology 16 (10), 589-604, 2019 | 3733 | 2019 |
| Hepatocellular carcinoma: a global view JD Yang, LR Roberts Nature reviews Gastroenterology & hepatology 7 (8), 448-458, 2010 | 1631 | 2010 |
| Integrative genomic analysis of cholangiocarcinoma identifies distinct IDH-mutant molecular profiles F Farshidfar, S Zheng, MC Gingras, Y Newton, J Shih, AG Robertson, ... Cell reports 18 (11), 2780-2794, 2017 | 714 | 2017 |
| The tumor microenvironment in hepatocellular carcinoma: current status and therapeutic targets JD Yang, I Nakamura, LR Roberts Seminars in cancer biology 21 (1), 35-43, 2011 | 472 | 2011 |
| Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma YH Yeo, JS Samaan, WH Ng, PS Ting, H Trivedi, A Vipani, W Ayoub, ... Clinical and molecular hepatology 29 (3), 721, 2023 | 436 | 2023 |
| Gender and menopause impact severity of fibrosis among patients with nonalcoholic steatohepatitis JD Yang, MF Abdelmalek, H Pang, CD Guy, AD Smith, AM Diehl, ... Hepatology 59 (4), 1406-1414, 2014 | 389 | 2014 |
| Cirrhosis is present in most patients with hepatitis B and hepatocellular carcinoma JD Yang, WR Kim, R Coelho, TA Mettler, JT Benson, SO Sanderson, ... Clinical Gastroenterology and Hepatology 9 (1), 64-70, 2011 | 354 | 2011 |
| New advances in the diagnosis and management of hepatocellular carcinoma JD Yang, JK Heimbach Bmj 371, 2020 | 346 | 2020 |
| Global incidence and prevalence of nonalcoholic fatty liver disease MLP Teng, CH Ng, DQ Huang, KE Chan, DJH Tan, WH Lim, JD Yang, ... Clinical and molecular hepatology 29 (Suppl), S32, 2022 | 323 | 2022 |
| Detection of circulating tumor cells and their implications as a biomarker for diagnosis, prognostication, and therapeutic monitoring in hepatocellular carcinoma JC Ahn, PC Teng, PJ Chen, E Posadas, HR Tseng, SC Lu, JD Yang Hepatology 73 (1), 422-436, 2021 | 305 | 2021 |
| HCC surveillance improves early detection, curative treatment receipt, and survival in patients with cirrhosis: a meta-analysis AG Singal, E Zhang, M Narasimman, NE Rich, AK Waljee, Y Hoshida, ... Journal of hepatology 77 (1), 128-139, 2022 | 275 | 2022 |
| Characteristics, management, and outcomes of patients with hepatocellular carcinoma in Africa: a multicountry observational study from the Africa Liver Cancer Consortium JD Yang, EA Mohamed, AOA Aziz, HI Shousha, MB Hashem, MM Nabeel, ... The lancet Gastroenterology & hepatology 2 (2), 103-111, 2017 | 268 | 2017 |
| Epidemiology and management of hepatocellular carcinoma JD Yang, LR Roberts Infectious Disease Clinics 24 (4), 899-919, 2010 | 265 | 2010 |
| Efficacy and safety of endoscopic radiofrequency ablation for unresectable extrahepatic cholangiocarcinoma: a randomized trial J Yang, J Wang, H Zhou, Y Zhou, Y Wang, H Jin, Q Lou, X Zhang Endoscopy 50 (08), 751-760, 2018 | 228 | 2018 |
| Diabetes is associated with increased risk of hepatocellular carcinoma in patients with cirrhosis from nonalcoholic fatty liver disease JD Yang, F Ahmed, KC Mara, BD Addissie, AM Allen, GJ Gores, ... Hepatology 71 (3), 907-916, 2020 | 209 | 2020 |
| A longer duration of estrogen deficiency increases fibrosis risk among postmenopausal women with nonalcoholic fatty liver disease JS Klair, JD Yang, MF Abdelmalek, CD Guy, RM Gill, K Yates, ... Hepatology 64 (1), 85-91, 2016 | 200 | 2016 |
| GALAD score for hepatocellular carcinoma detection in comparison with liver ultrasound and proposal of GALADUS score JD Yang, BD Addissie, KC Mara, WS Harmsen, J Dai, N Zhang, ... Cancer Epidemiology, Biomarkers & Prevention 28 (3), 531-538, 2019 | 198 | 2019 |
| Purification of HCC-specific extracellular vesicles on nanosubstrates for early HCC detection by digital scoring N Sun, YT Lee, RY Zhang, R Kao, PC Teng, Y Yang, P Yang, JJ Wang, ... Nature communications 11 (1), 4489, 2020 | 183 | 2020 |
| Risk factors for intrahepatic cholangiocarcinoma: association between metformin use and reduced cancer risk R Chaiteerakij, JD Yang, WS Harmsen, SW Slettedahl, TA Mettler, ... Hepatology 57 (2), 648-655, 2013 | 178 | 2013 |
